"Synergistic Anticancer Activity of Topotecan— Cyclin-Dependent Kinase Inhibitor Combinations against Drug-Resistant Small Cell Lung Cancer (SCLC) Cell Lines"
written by Gerhard Hamilton, Ulrike Olszewski, Lukas Klameth, Ernst Ulsperger, Klaus Geissler,
published by Journal of Cancer Therapy, Vol.4 No.8A, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef